These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6301231)

  • 1. Cytotaxin receptors on human neutrophils: modulation of C5a and peptide receptor number.
    Nelson RD; Chenoweth DE; Solomkin JS; Solem LD
    Agents Actions Suppl; 1983; 12():274-89. PubMed ID: 6301231
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotactic deactivation of human neutrophils: relationship to loss of cytotaxin receptor function and temporal nature of the phenomenon.
    Nelson RD; Fiegel VD; Herron MJ; Simmons RL
    J Reticuloendothel Soc; 1980 Sep; 28(3):285-94. PubMed ID: 7411541
    [No Abstract]   [Full Text] [Related]  

  • 3. 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucyl-phenylalanine (FLMP) to its receptor on human granulocytes. A note of caution.
    Atkinson JP; Simchowitz L; Mehta J; Stenson WF
    Immunopharmacology; 1982 Feb; 4(1):1-9. PubMed ID: 6277829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periodontal diseases and impaired neutrophil function.
    Van Dyke TE; Levine MJ; Al-Hashimi I; Genco RJ
    J Periodontal Res; 1982 Sep; 17(5):492-4. PubMed ID: 6218280
    [No Abstract]   [Full Text] [Related]  

  • 5. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
    Charo IF; Yuen C; Perez HD; Goldstein IM
    J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two neutrophil populations in human blood with different chemotactic activities: separation and chemoattractant binding.
    Harvath L; Leonard EJ
    Infect Immun; 1982 May; 36(2):443-9. PubMed ID: 7085067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of granulocyte response to the chemoattractant F-Met-Leu-Phe.
    Dahlgren C; Stendahl O
    Adv Exp Med Biol; 1982; 155():107-12. PubMed ID: 6297266
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotactic deactivation of human neutrophils: protective influence of phenylbutazone.
    Nelson RD; Gracyk JM; Fiegel VD; Herron MJ; Chenoweth DE
    Blood; 1981 Oct; 58(4):752-8. PubMed ID: 6268231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phagocytosis-induced modulation of human neutrophil chemotaxis receptors.
    Lane TA; Lamkin GC; Windle BE
    Blood; 1981 Aug; 58(2):228-36. PubMed ID: 6264995
    [No Abstract]   [Full Text] [Related]  

  • 12. Specificity and reversibility of chemotactic deactivation of human monocytes.
    Falk W; Leonard EJ
    Infect Immun; 1981 May; 32(2):464-8. PubMed ID: 6265358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthetic chemotaxins but not interactions with serum-derived chemotaxins.
    Gray GD; Smith CW; Hollers JC; Chenoweth DE; Fiegel VD; Nelson RD
    Antimicrob Agents Chemother; 1983 Nov; 24(5):777-83. PubMed ID: 6318656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of loss of human neutrophil chemotaxis following thermal injury.
    Nelson RD; Hasslen SR; Ahrenholz DH; Solem LD
    J Burn Care Rehabil; 1987; 8(6):496-502. PubMed ID: 3436972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulus-specific deactivation of chemotactic factor-induced cyclic AMP response and superoxide generation by human neutrophils.
    Simchowitz L; Atkinson JP; Spilberg I
    J Clin Invest; 1980 Oct; 66(4):736-47. PubMed ID: 6252250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of PMN receptors for chemotactic peptides.
    Fletcher MP; Gallin JI
    Surv Immunol Res; 1983; 2(2):139-44. PubMed ID: 6316458
    [No Abstract]   [Full Text] [Related]  

  • 18. Cytotaxin receptors of neutrophils: evidence that F-methionyl peptides and pepstatin share a common receptor.
    Nelson RD; Ackerman SK; Fiegel VD; Bauman MP; Douglas SD
    Infect Immun; 1979 Dec; 26(3):996-9. PubMed ID: 528062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the interaction of human C5a and C5a des Arg with human monocytes and neutrophils: flow cytometric and chemotaxis studies.
    Yancey KB; Lawley TJ; Dersookian M; Harvath L
    J Invest Dermatol; 1989 Feb; 92(2):184-9. PubMed ID: 2493055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation.
    Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL
    Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.